VENUSREM / NSE / Biotechnology & Drugs
Venus Remedies
1Y Price Trend
Key Information
Recommendations
Target High2,043.15
Target Low423.7
Target Mean0
Target Median0
Risk Metrics
Overall RiskHigh risk
Board Risk56.52
Key Analysis
Overall score, performance score, return rating, defensive, aggressive, and balanced views.
Download appProjection Analytics
Best-case, base-case, worst-case, and dynamic AI projection views.
Download appLatest stock news
Sumeet Bagadia recommends five breakout stocks to buy today - Latent View Analytics, Cantabil Retail India Limited, Gujarat Ambuja Exports, Venus Remedies, and Jindal Stainless.
Sumeet Bagadia recommends five breakout stocks to buy today: CEAT, V I P Industries, Blue Jet Healthcare, HEG, and Venus Remedies.
Shares of Venus Remedies rose 14.3% to ₹ 356.65 after the US FDA granted QIDP designation to its product VRP-034, targeting bloodstream infections. This designation offers regulatory benefits, highlighting the need for safer polymyxin therapies. The stock has rebounded 12% this month.
Venus Remedies gained over 8 per cent today after securing marketing authorisation for three variants of chemotherapy drugs in Israel and Colombia
Venus Remedies' German subsidiary Venus Pharma GmbH has received this approval for 500mg, 1g and 2g injections of this last-recourse antibiotic.
Stock FAQs
What is the symbol and ISIN of Venus Remedies?
Venus Remedies has the symbol VENUSREM and ISIN - INE411B01019.
What is the current price of Venus Remedies?
Venus Remedies is currently trading at INR 1,740.00.
What are the year high and year low of Venus Remedies?
Venus Remedies has a year high of INR 2,043.15 and a year low of INR 423.70.
What is the market capitalization of Venus Remedies?
Venus Remedies has a market capitalization of INR 2,335.15 crore.
What is the P/E ratio of Venus Remedies?
Venus Remedies has a P/E ratio of 10.66.
What is the dividend yield of Venus Remedies?
Venus Remedies has a dividend yield of 0.59%.
How is the financial performance of Venus Remedies based on revenue, net income, and EPS?
Venus Remedies has revenue of INR 7,696.00 crore, net income of INR 1,027.80 crore, and EPS of INR 76.92.
What is the book value of Venus Remedies?
Venus Remedies has a book value of INR 426.16.
What is the debt-to-equity ratio of Venus Remedies?
Venus Remedies has a debt-to-equity ratio of NA.
What are the price-to-book and price-to-sales ratios of Venus Remedies?
Venus Remedies has a price-to-book ratio of 4.08 and a price-to-sales ratio of 0.30.
© SharekeyX | Rusaka Technologies 2024-2026